Syncom Formulations (India) Limited reported earnings results for the first quarter ended June 30, 2024. For the first quarter, the company reported sales was INR 872.55 million compared to INR 598.36 million a year ago. Revenue was INR 885.94 million compared to INR 617.11 million a year ago. Net income was INR 76.33 million compared to INR 43.96 million a year ago. Basic earnings per share from continuing operations was INR 0.11 compared to INR 0.07 a year ago. Diluted earnings per share from continuing operations was INR 0.11 compared to INR 0.07 a year ago.
